Category: SeaPRwire

SHENZHEN, Feb 24, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received the acceptance from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of mild to moderate atopic dermatitis on 24 February 2026. The Product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. The NDA has been approved for inclusion in the Priority Review List by the Center for Drug Evaluation (CDE) of the NMPA based on its qualification as a “new variety, dosage form and specification of pediatric drug that conforms to the physiological characteristics of children”, which is expected to accelerate the Product’s review process for marketing approval in the AD indication. Impressive phase III trial data in AD Its Priority Review is expected to accelerate its NDA approval Ruxolitinib phosphate cream was approved for marketing by the NMPA in January 2026, becoming the first and only targeted drug approved in China for the treatment of vitiligo. The acceptance of this NDA for the additional indication of AD marks a key milestone in the Product’s expansion into multiple therapeutic areas. Ruxolitinib phosphate cream has achieved positive results in a randomized, double-blind, placebo-controlled Phase III clinical trial in China for mild to moderate AD. Robust Efficacy: The Product successfully met its primary endpoint, demonstrating that a significantly higher proportion of subjects treated with ruxolitinib phosphate cream achieved IGA (Investigator’s Global Assessment) of 0 or 1 with at least two grades of reduction from baseline at week 8, compared with placebo (63.0% vs 9.2%, P < 0.001). For the key secondary endpoint, the proportion of subjects achieving at least a 75% improvement from baseline in the Eczema Area and Severity Index score (EASI 75) of treatment with ruxolitinib phosphate cream was also significantly higher than that of the placebo group, at week 8 (78.0% vs 15.4%, P < 0.001). Favorable Safety Profile: The severity of treatment-emergent adverse events (TEAE) during the treatment period was mostly mild or moderate, with no TEAEs leading to discontinuation of the study drug. Overall, ruxolitinib phosphate cream was safe and well-tolerated. Furthermore, the NDA has been approved for inclusion in the Priority Review List. According to relevant NMPA regulations, the review timeline for marketing applications subject to Priority Review and Approval Procedure is substantially shortened—from the standard 200 days to 130 days. This significant reduction in the review timeline is expected to accelerate the marketing process of ruxolitinib phosphate cream for the AD indication, benefiting a wide range of patients at an earlier date. Building an integrated AD solution, strengthening Dermavon’s leadership in dermatology AD is a chronic, recurrent and inflammatory dermatologic disease, with the main clinical manifestations of dry skin, chronic eczema-like lesions and obvious itching or pruritus, which may seriously affect the quality of life of patients. It is estimated that there were over 54 million AD patients in China as of 2024. Based on SCORAD scores, mild to moderate AD accounts for 98% of these cases, representing over 52.5 million patients[1]. Topical drugs are the most basic treatment for AD. Traditional topical medications such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) have clinical pain points with long-term adverse reactions or limited efficacy, therefore novel treatments are urgently needed. Dermavon has developed a comprehensive “treatment + care” integrated solution for AD. In addition to the topical formulation ruxolitinib phosphate cream for mild-to-moderate AD, the portfolio also includes the injectable biological agent Comekibart Injection (MG-K10) for moderate-to-severe AD, the oral small molecule targeted drug CMS-D001 for moderate-to-severe AD, and the Heling Soothing Product Series for daily repair, to meet the management needs of AD patients from treatment to daily care. Simultaneously, the acceptance of the NDA for the AD indication will strengthen Dermavon’s strategic layout in the field of skin treatments and create synergies with its commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s market competitiveness and brand influence in the field of skin health. More Information About Ruxolitinib Phosphate Cream Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte. In China, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. In the U.S., ruxolitinib phosphate cream is the first topical JAK inhibitor approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of non-segmental vitiligo in patients aged 12 years and older, and for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable[2]. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3]. The Group, through its subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary). Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference:1. China Insights Consultancy’s industrial report2. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-additional-fda-approval-opzelurar-ruxolitinib3. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

JIAXING, China – February 13, 2026 – On the eve of the 2026 Spring Festival, the “Relax Jiaxing” international promotional campaign, organized by the Jiaxing Municipal Bureau of Culture, Radio, Television, and Tourism in partnership with Putike International Travel Service,was successfully launched. The initiative invited celebrated Malaysian travel content creators @Janice&Jaguar on a curated three-day journey through Jiaxing, designed to capture the authentic flavors of the Chinese New Year and the timeless allure of the Jiangnan region. Documenting their experiences and sharing them with global audiences via Instagram, YouTube, and other international social media platforms, the influencers spotlighted Jiaxing’s vibrant Spring Festival traditions and distinctive Jiangnan character, extending an invitation to overseas travelers to “come back to Jiaxing and experience the festivities.” Where the Festive Spirit Reigns: Jiaxing Debuts Its Captivating “Chinese New Year Look” The meticulously curated itinerary, built around the theme of “New Year flavor,” linked a series of cultural landmarks immersed in festive ambiance. At Puyuan Fashion Ancient Town, the influencers marveled at the sweeping lantern displays, dazzling light installations, and strategically placed New Year decorations—while also bearing witness to the breathtaking spectacle of “Datiehua” (molten iron fireworks), an intangible cultural heritage performance that radiated both passion and romance, deeply rooted in traditional folk customs. On the iconic Yuehe Historical Street, home to distinctive attractions such as the Zongzi (rice dumpling) Museum, time-honored brands including Shendang rice wine and Weidefeng offered an authentic taste of local heritage. The bustling array of traditional New Year goods evoked cherished memories of a Jiaxing-style Spring Festival. Meanwhile, Nanhu Tiandi, Jiaxing’s most vibrant and trendy commercial district, has likewise embraced its festive transformation. Adorned with a series of celebratory art installations that seamlessly blend Jiangnan elegance with contemporary aesthetics, the area also hosts a lively New Year market running through the Lantern Festival. With photogenic scenes at every turn, the district embodies a stylish reinterpretation of traditional Chinese New Year spirit—where heritage meets modernity in the most captivating way. Encountering Ancient Jiangnan Towns: Immersing in the Slow Rhythms of Life Beyond the vibrant festive atmosphere, the influencers delved into Jiaxing’s rich tapestry of ancient cities and towns, exploring the city’s profound historical legacy across different eras and perspectives. At the Zicheng Archaeological Site Park, they wandered along the millennia-old city walls, listening to the silent stories embedded in every stone and experiencing the flow of Jiaxing’s history through centuries of change. Continuing to the Nanhu Tourist Resort, they ascended the iconic Misty Rain Pavilion against a backdrop of mist and drizzle, taking in sweeping views of Nanhu Lake and gazing upon the historic Red Boat—a timeless symbol enshrined in China’s revolutionary memory. At this convergence of red culture and Jiangnan scenery, they came to appreciate the city’s layered cultural identity. As night descended, an evening boat cruise offered a poetic conclusion to the day’s journey, weaving together the shimmering lights of Jiaxing’s waterfront. Gliding along the calm waters, the boat revealed a panorama of architectural silhouettes lining the shores—each telling its own story—unfolding like a living scroll of a “city that never sleeps,” both timeless and enchanting. “To Discover the Soul of Jiangnan’s Ancient Towns, Look to Jiaxing.” Xitang and Shendang unfold like two quietly turned pages from the chronicles of authentic Jiangnan life. Xitang Ancient Town, celebrated as a “living millennium-old town,” preserves remarkably intact clusters of Ming and Qing architecture, defined by its signature layout of “numerous bridges, winding lanes, and sheltered corridors.” Here, time seems suspended in a gentle, harmonious rhythm. Shendang Ancient Town, by contrast, offers a more tranquil and introspective experience. Largely untouched by excessive commercial development, it allowed the influencers to immerse themselves in the unspoiled, slow-paced essence of Jiangnan life. This journey by the Malaysian content creators stands as a vivid testament to Jiaxing’s cultural tourism vision—using the Spring Festival as a cultural bridge to share the refined aesthetics of Jiangnan with the world. Where time-honored New Year traditions converge with the legacy of ancient towns, and where revolutionary heritage intertwines with contemporary luminous artistry, Jiaxing reveals its uniquely inclusive and multifaceted character. It is crafting a fresh narrative for Spring Festival travel—one that blends festive richness with heartfelt experiences. Come, and discover a different kind of Jiangnan Chinese New Year.

On February 14, 2026, a major announcement was made: The original Chinese AI algorithm "Congzi" was officially released under an open-source license. In 2025, after being tested by multiple open-source AI companies from China and the United States, this "the world's first physically-native intelligent engine" technology, which restructures the underlying logic of AI based on first principles, became a significant driving force for the technological leap in the AI field in 2025. Moreover, with its low-barrier adaptability advantage, it enabled AI to progress from "imitating human language" to "understanding the language of the universe", allowing an ordinary AI to be upgraded in 5 minutes, bringing a disruptive change to the AI for Science field. Breaking through tradition: Reconstructing the underlying logic of AI This breakthrough technology is based on the first-principles approach, eliminating the traditional AI "black box illusion". The revolutionary aspect of Congzi AI lies in its unified core equation of electromagnetic force and nuclear force, which can naturally derive the Maxwell equations, the periodic law of elements and the quantization of electron orbits, among other key achievements, without the need for phenomenological parameters (such as e, ε0). Four major modules: Strengthening the technical foundation The Congzi AI reconfigures the AI cognitive thinking ability through four major modules and five core components. The Congzi Force-Speed Relativistic Reasoning Core constrains the causal chain within the momentum conservation, reducing the illusion rate of scientific question answering by 92%; the computing system can be arbitrarily divided into independent sub-domains for full-efficiency parallel computing; the cross-scale unified field engine covers multi-scale scenarios ranging from 10⁻¹⁵m (quarks) to 10⁻³m (materials), predicting the proton-proton repulsion force at 0.7fm with an error less than 3.6%, surpassing AlphaFold, achieving "force generation" rather than merely "structure prediction"; the quantum form memory compressor compresses the trillion-token-scale knowledge base to within 1GB, supporting cross-disciplinary mapping on ordinary servers within milliseconds, without relying on expensive H100/GPU clusters; the Soul Existence Verification Protocol (SEV Protocol) provides a verifiable path for each scientific assertion, allowing AI conclusions to be fully traceable and verifiable, completely solving the problem of AI "lying". Zero-barrier integration: Smooth upgrade experience The open-source AI algorithm of Congzi adheres to the principles of "low threshold and high compatibility". Developers only need to complete the integration in three steps and do not need to retrain the model. It is compatible with mainstream hardware such as Tsinghua Unigroup, Horus, and Intel CPU, and compatible with mainstream AI architectures such as Qwen, DeepSeek, AWS-Rufus, Llama, and GPT. It enables "zero-cost upgrade". Multiple industry giants have secretly deployed (under pseudonyms): for example, the material simulation error of N2 is less than 3%, the financial AI yield of DSR1 has increased by 22%, and the protein folding simulation speed of AL cloud has been accelerated by 10⁵ times, far exceeding traditional molecular dynamics methods. Open-source ecosystem is open: facilitating technology implementation The Congzi open-source ecosystem is fully open, providing developers with a complete set of guidance and resources, including tutorials and other materials. These resources have been launched on the designated platform. The first batch focuses on key scientific scenarios such as drug molecule prediction and chip material simulation, covering cutting-edge fields such as biomedicine and advanced manufacturing. We sincerely invite global partners to collaborate and jointly build a new ecosystem. The four theoretical attachments and a 5-minute upgrade guide video can be downloaded from the official website: Official platform: https://congzisupersci.com.cn/；https://congzijdc.cc/ Open source website: https://github.com/congzijdc/CongziAIOS Super Holographic Technology Cooperation: congzi@supersci.cn；congzijdc@supersci.cn Optimize Baidu Wenxin video links：https://youtu.be/cYQhfq1tudM Upgrade Qianwen video links：https://youtu.be/OMBOdLpWVzs

Seattle, Washington – February 10, 2026 – (SeaPRwire) – Singer-songwriter Dr. Don has surpassed one million views on YouTube across three of his music videos in less than a year, marking a major digital milestone for the independent artist. The songs “Beautiful Vibes,” “Vodka Tonight,” and “Ruled by Time” have each crossed the seven-figure mark on the platform, with additional short-form video versions also reaching significant view counts. Dr. Don’s milestone highlights his rise as an independent artist, proving that multiple songs can attract large audiences without relying on traditional promotion. Strong performance across both full-length and short-form videos shows his ability to connect with listeners in different ways, marking a significant step in his career and illustrating how music can thrive organically in today’s digital landscape. According to Dr. Don, “Ruled by Time” has become the strongest engagement anchor among the releases, continuing to generate repeat viewers, lyric-based comments, and ongoing discussion. He said the video has maintained active interaction well beyond its initial surge. Dr. Don described “Ruled by Time” as a standout, noting its strong and sustained engagement. “It has become the strongest anchor among my releases. The video continues to show unusually high interaction with repeat viewers, lyric-based comments, and ongoing discussion,” he said. “Seeing people reference the lyrics and share their experiences shows the music is landing in a real way.” The surge comes without a label machine, radio pipeline, or marketing firm behind it. Dr. Don is building this momentum on his own, releasing music independently and growing his audience one listener at a time. Crossing the million-view mark across three separate songs in less than a year places him in rare company among truly self-directed artists. The numbers reflect not a campaign, but a connection, powered by repeat viewers, shared links, and sustained conversation around the music. Each milestone strengthens his position as a solo creator proving that scale is still possible without gatekeepers. With multiple videos now hitting seven figures, Dr. Don is expanding his platform in real time, connecting with listeners globally while preparing his next projects. His work illustrates how focus, consistency, and authenticity can turn digital engagement into a tangible career milestone. This is where music meets momentum. Visit Dr. Don’s official YouTube channel and follow him on social media for updates. About Dr. Don Dr. Don is a singer-songwriter and performer known for blending introspective lyrics, rich baritone vocals, and expressive movement to create immersive musical experiences. His work explores the complexities of human emotion, vulnerability, and personal growth. Beyond music, he draws on a background in law to inform his understanding of human behavior and storytelling, making each performance a unique reflection of artistry and self-expression. Media Contact Dr. Don E: don@drdonmusic.com W: https://drdonmusic.com/

Historic insurance partnership with Great American Insurance Group sets new standard for player protection KUALA LUMPUR, Malaysia – February 09, 2026 – (SeaPRwire) – playX today announced a milestone achievement in player protection, unveiling an industry-leading insurance policy secured through a strategic partnership with Great American Insurance Group (GAI), a trusted provider of gaming insurance solutions since 1995. The announcement was made during a special company event in Kuala Lumpur, highlighting playX’s continued commitment to strengthening financial safeguards for players across its platform. Official Video: https://www.youtube.com/watch?v=EpvceD-HJyU What This Means for Players The policy directly protects all playX players. If playX ever ceases operations, players can file claims directly with GAI to recover their funds — a first in online gaming history. Direct claim rights with Great American Insurance Group Platform insolvency protection for all player funds Backed by GAI’s 30-year track record in gaming insurance Guinness-verified player protection in online gaming “This isn’t just a title — it’s a guarantee that our players’ funds are protected by an independent, globally recognized insurer, not just our promises,” said Mark Carter, CEO of playX. About playX Premier online gaming platform serving Southeast Asia, combining cutting-edge technology with industry-leading security. About Great American Insurance Group Century-old insurance provider; Fidelity & Crime division has led gaming insurance since 1995. Official Channels Facebook: https://www.facebook.com/playX.my Instagram: https://www.instagram.com/playx.my/ Telegram: https://t.me/playXofficial YouTube: https://www.youtube.com/@playXOfficial8 Media contact Brand: playX Contact: Media team Email: marking@playxgaming.com Website: https://playx.my

New York, NY – February 01, 2026 – (SeaPRwire) – Recently, the world’s only Pokémon card graded PSA 10 – Pikachu Illustrator – once again became a focal point of global attention across the collectibles and cultural landscape. As a long-term contributor to TCG infrastructure and the broader collectibles ecosystem, The Collectors Grid(TCG.Zone) participated in and witnessed this historically significant moment. Recognized as one of the most iconic works in Pokémon card history, Pikachu Illustrator is distinguished not only by its extreme rarity, but also by its symbolic representation of Pokémon culture, artistic value, and generational memory. The Legendary Status of the World’s Only PSA 10 According to publicly available information, the world’s only PSA 10 “Pikachu Illustrator” card is currently owned by Logan Paul. The card was involved in a high-profile transaction in 2022, valued at nearly USD 5.3 million, marking a defining milestone in the history of Pokémon card collecting. The Industry Significance of Goldin Auctions Although Logan Paul’s acquisition of the card did not take place through Goldin, the Goldin auction platform has continued to play an important role in the card’s contemporary circulation and visibility. As one of the world’s most influential high-end collectibles auction platforms, Goldin’s auction framework and the attention it generates brought renewed global focus to this legendary card, further positioning Pokémon cards within the broader mainstream collectibles market. Netflix Documentary Captures a Cultural Moment Amid the phenomenon-level attention generated by this card on the Goldin platform, Netflix documented the full auction process and produced a dedicated documentary. Approached from a cultural and historical perspective, the documentary highlights the unique position of Pikachu Illustrator within the modern collectibles ecosystem, elevating it beyond price alone and framing it as a lasting cultural reference. Global Participation and TCG.Zone’s Involvement The discussions and auction activity surrounding Pikachu Illustrator attracted participation from top collectors, institutions, and professional teams from around the world. TCG.Zone was among the active participants in the bidding process. During the auction, TCG.Zone submitted a bid of USD 5,000,000. Although the bid was ultimately surpassed by a higher offer, TCG.Zone remained deeply engaged throughout the process and witnessed this pivotal moment firsthand. Continuing to Follow the Card’s Future Trajectory In post-auction interviews, TCG.Zone stated that this participation does not mark an endpoint. The team will continue to closely monitor the movement and future trajectory of the world’s only PSA 10 Pikachu Illustrator, and does not rule out participating again should the right opportunity arise. This event represents more than an auction. It stands as a collective reflection on rarity, cultural identity, and long-term value. The story of Pikachu Illustrator continues to unfold,and remains an enduring chapter in the global history of Pokémon card collecting. Social Links Twitter: https://x.com/tcgzoneofficial Instagram: https://www.instagram.com/tcgzoneofficial/ Telegram: https://t.me/tcgzoneofficial Media Contact Brand : The Collectors Grid (tcg.zone) Contact: Annie Email: hi@tcg.zone Website: https://www.tcg.zone

SHENZHEN, Jan 30, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need. Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential. The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone’s real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred. This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s position in the field of skin health. Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China. About Vitiligo Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance. More About Ruxolitinib Phosphate Cream Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary). Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference: 1. The U.S. FDA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream 2. The EMA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar 3. The clinical studies information can be found on the Opzelura® official website, as follows: https://www.opzelura.com/opzelura-prescribing-information 4. China Insights Consultancy’s industrial report CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/

Moscow, Russia – January 31, 2026 – (SeaPRwire) – Expert Dialogues were held for the first time within the Open Dialogue framework at the Russia National Centre in Moscow on 30 January. The forum focused on five major megatrends shaping global economic, technological, and social development, bringing together international experts to explore how these forces will influence societies and industries in the decades ahead. Organized by the Russia National Centre in partnership with the Centre for Cross-Industry Expertise “The Third Rome” and supported by the Presidential Executive Office, the forum brought together experts from around the world to discuss economic, technological, and social transformations. Maksim Oreshkin, Deputy Head of the Russian Executive Administration for Global Trends, presented five key megatrends that, he said, are already shaping global development and will continue to influence the world in the coming decades. “By 2026, Open Dialogue has become an international platform uniting experts from across the world to discuss the future of the planet, the global economy, and society,” Oreshkin said. “Understanding these processes is essential for preparing for change and leveraging it in the interests of nations and, above all, people. Today, I will focus on five key megatrends — while not treating artificial intelligence as a separate trend, because it has already become an integral part of our lives.” 1. A New Global Economic Paradigm: Globalisation 2.0 A shift from traditional globalisation to a more decentralised system was described. BRICS+ countries now play a growing role in the global economy, technological development, and demographic trends, while the Global South is increasingly engaging in direct trade and national-currency settlements. “Globalisation hasn’t ended; it has changed,” Oreshkin said. “Sovereignty — at state, social, and economic levels — is now the key to competitiveness. Only countries that preserve all three levels can lead in a multipolar world.” China, the USA, India, and Russia are identified as major global powers, while highlighting emerging growth centres such as Indonesia and “connector countries” like the United Arab Emirates. Digital platforms and decentralised networks are also becoming independent participants in the world economy. 2. Platformisation and Institutional Automation The second megatrend highlights the rise of platforms and automation across all sectors. Platforms and algorithms are increasingly shaping decision-making in healthcare, education, finance, trade, and beyond. “Platform solutions enhance efficiency and reduce transaction costs through self-adjusting algorithms,” Oreshkin said. “Countries without technological sovereignty risk becoming dependent on external platforms, which can have strategic consequences during conflicts.” 3. Transformation of the Global Financial System It was noted that traditional financial models face mounting challenges, including rising public debt, widening inequality, and geopolitical fragmentation. Technologies such as blockchain, artificial intelligence, and digital platforms are creating alternative financial mechanisms, including decentralised finance. “The traditional model of cross-border payments is under pressure. Decentralised systems and digital technologies are reshaping the financial system,” he said. 4. Demographic Shifts and Challenges The fourth megatrend concerns global population dynamics. Global fertility rates have fallen sharply, with some countries facing critical declines. By the end of the 21st century, the working-age population may shrink significantly, while the proportion of elderly people rises, placing pressure on pension systems and social services. “Even in Africa, the ratio of elderly to working-age population will rise to 30%, and globally to 56%,” Oreshkin explained. “Education demand will decrease, but healthcare and social service needs will grow. These interconnected trends will amplify each other.” 5. Human Capital Development in the Technological Era The final megatrend focuses on human capital in a rapidly changing technological environment. Autonomous systems, digital platforms, and artificial intelligence are transforming education, work, and healthcare, while biotechnologies expand human capabilities. “AI is both a challenge and an opportunity,” Oreshkin said. “It allows personalized learning paths and supports teachers. Professions are changing: mid-level specialists will be in demand, and companies must retrain employees from junior positions. The social sphere will also evolve, ensuring active longevity in the new demographic era.” Global Perspective Throughout the presentation, Oreshkin illustrated each trend with real-life examples from different continents: a manager from Asia, a farmer from Africa, and a homemaker from Eastern Europe. He highlighted that innovations in Africa could improve education and healthcare, Eastern Europe may see rising living standards and more efficient social systems, and Asia will require reskilling to meet changing labor demands. “The world has entered a period of significant change in finance, demography, and other spheres. States, companies, and individuals must be prepared. Those who understand and adapt will shape the future,” Oreshkin concluded. Open Dialogue on Air This year, Open Dialogue introduced a podcast format — Open Dialogue on Air — featuring global experts discussing key trends in international development. Participants include award-winning Chinese sci-fi writer Chen Qiufan, Dr. Selina Neri of the Future Readiness Academy, Dr. Rais Hussin of EMIR Research (Malaysia), Prof. Wang Feng of UC Irvine, and global strategist Dr. Parag Khanna. First held in April 2025 at the Russia National Centre, the Open Dialogue brought together over 3,000 experts from dozens of countries. By presidential decree, it will now be held annually. Social Links Telegram: https://t.me/gowithrussia VK: https://vk.com/gowithrussia OK: https://ok.ru/gowithrussia DZen: https://dzen.ru/gowithrussia Contact for the media Brand: Russia National Centre Contact: Media team Email: Pressa@russia.ru Website: https://russia.ru Essay Submission: https://dialog.russia.ru/en/

2026年1月30日 - (SeaPRwire) - 当自由行旅客在台中想找一间「值得专程上山」的餐厅，很多新加坡、马来西亚与香港旅人会把答案指向同一个地方：台中新社半山腰的无菜单料理餐厅「飞花落院」。最近，飞花落院也登上网络节目《上课了！地缘经济学》专访，再次把这间「不用报地址、计程车司机也知道」的名店推上话题焦点。飞花落院创办人魏幸怡受访时表示，海外旅客喜欢飞花落院不只是因为美食，关键更在于「你会经历什么」：一段上山看景、入席变得优雅、在庭院里把时间慢下来的旅程。 上山吃一餐，也把台中夜景与日式庭园一次打包 飞花落院位在海拔四百多公尺的新社，白天可俯瞰台中城市景，夜晚更是百万夜景等级；加上日式庭园、包厢氛围与大量回收木材打造的空间细节，让不少星马、香港旅客形容「很像把京都的静，和台湾山城的景放在同一张明信片里」。而节目中最让观众惊呼的细节，则是「燕子住得比谁都久」。 魏幸怡分享，飞花落院命名源自唐诗苏颋〈山驿闲卧即事〉名句：「息燕归檐静，飞花落院闲。」巧的是，建造期间燕子真的飞来筑巢、还生了小燕子，团队因此停工等待并保留燕巢至今。她笑说：「它是我们这里住最久的居民，也带来很多福气和缘分。」这段故事也成为海外旅客最爱拍照、最爱分享的「只有飞花落院才遇得到」的记忆点。 在地食材＋国际主厨，把台湾最好的食材端上世界餐桌 在料理上，飞花落院以无菜单形式呈现，让每次到访都像开盲盒，但惊喜背后其实很有脉络：一端是土地，一端是国际。魏幸怡指出，餐厅会把新社菇类、大坑竹笋，以及水井地区特别适合生长的根茎作物做成「在地三重奏」；海味则与宜兰大溪渔港渔夫合作，渔获不进拍卖市场，直接在船上挑好、定期直送厨房，把最新鲜的状态交给料理。 她也观察，许多新加坡、香港旅客其实最想听的，是台湾食材背后的故事：这块土地原本是一片竹林、如何保留原始树木、为什么空间大量使用竹子向土地致敬。于是飞花落院把「说故事」变成餐桌的一部分，让海外旅客不只吃到台湾，还能「听懂台湾」。 节目中也呈现飞花落院的国际视野。来自意大利、旅居日本金泽的客座主厨 Matteo，将意大利的灵魂、日本的细腻与台湾山海食材做创意结合；他形容台湾的山与海，让他想起意大利与日本的风土相似，因此更能用自己的语言读懂台湾味。甜点更把「只有台湾才有的惊喜」端上桌，例如以莲雾入甜点，搭配贵妃乌龙与接骨木花糖浆，现点现做、香气堆叠，让不少海外旅客直呼「这个在海外很少吃得到」。 魏幸怡也坦言，飞花落院一路走来并非没有挑战。早期台中市场平均客单价多落在千元上下，飞花落院一开始就设定在三千元以上，必须用时间让客人理解「看不见的用心」：食材挑选、料理设计、空间与服务的完整性。如今，餐厅累积了不少回访三、四十次的熟客，也成为星马、香港旅客愿意专程把新社排进行程的理由，因为他们买到的不是「吃饱」，而是一段被认真款待的旅行片段。欢迎喜爱四季更迭的你到飞花落院走走：https://www.inflorescence.com.tw/

In Collaboration with MAGO Moon Museum, Opening the “$VIVI RWA MARKET” Singapore – January 29, 2026 – (SeaPRwire) – LEGENDARY HUMANITY, a Singapore-based company listed on Gate.io, has announced the launch of the “$VIVI RWA MARKET,” a new Real World Asset (RWA) marketplace enabling the purchase of exhibited works by contemporary artist Mago Nagasaka. Developed in collaboration with the MAGO Moon Museum, this launch marks a significant milestone in LEGENDARY HUMANITY’s ongoing efforts to bridge cultural value and digital infrastructure through real-world assetization. Digitalizing Humanity’s Masterpieces Through AI 3D Scanning Technology – A New Purchasing Experience Led by LEGENDARY HUMANITY LEGENDARY HUMANITY PTE. LTD. (Headquarters: Singapore; CEO: Takamasa Suzuki) has officially opened the “$VIVI RWA MARKET,” an RWA marketplace where visitors can directly purchase artworks exhibited in the online museum “MAGO Moon Museum,” created by contemporary artist Shingo Nagasaka. This initiative forms part of the “VIVI PROJECT,” which aims to digitize humanity’s masterpieces into digital assets through high-precision, non-contact AI-integrated 3D scanning technology. Through this platform, visitors are able to acquire artworks they have viewed within MAGO Moon Museum as RWAs, enabling a deeper engagement with the artist’s worldview and creative philosophy. Overview Name: $VIVI RWA MARKET Opening Date: Thursday, January 29, 2026 URL: https://mondo.lhvivi.io/ About “$VIVI RWA MARKET” The “$VIVI RWA MARKET” is an RWA marketplace dedicated to the acquisition of artworks and is embedded within the online museum MAGO Moon Museum. Seamless Pathway from Viewing to Purchase Users can seamlessly transition from an artwork’s exhibition page to its corresponding RWA product page, creating a unified experience from online viewing to ownership. Integration of Physical and Digital Asset Design Each artwork includes the following structured information: Physical artwork details (size, materials, condition, provenance) High-resolution digital data generated through AI 3D scanning Artist profile and project background information along with other curated metadata. This structure allows users to acquire artworks with a proper understanding of their cultural and artistic value. Ecosystem Holding Functionality Acquired works will gradually gain viewing and management functionality within the VIVI ecosystem. While future integration with VIVI COiN is under consideration, the current initiative is focused solely on enhancing the preservation, appreciation, and understanding of the artworks. About LEGENDARY HUMANITY and the VIVI PROJECT LEGENDARY HUMANITY promotes the “VIVI PROJECT,” which digitizes legendary masterpieces created by humanity into digital assets using high-precision, non-contact, AI-integrated 3D scanning technology. The project operates under the vision of “Bringing the beauty of humanity to AI and the future.” Targeted assets include: Legendary fashion collections Historical architecture and cultural masterpieces Famous trading cards Artworks, including those exhibited at MAGO Moon Museum and other assets that can be described as humanity’s masterpieces. The VIVI PROJECT aims to: Digitize assets as digital cultural heritage Tokenize them as RWAs for global circulation Exhibit them in both online and physical museums thereby building new infrastructure that harmonizes cultural and economic value. NEXT SOCIETY (Gacha Location): https://nextsociety.lhvivi.io RWA Market Roadmap The launch of the “$VIVI RWA MARKET” represents the first phase of RWA market functionality within the VIVI PROJECT. Planned future developments include: VIVI FASHION (RWA for the fashion domain) VIVI TRADING CARD (RWA for the trading card domain) VIVI ART WORK (RWA for art collections) with future integration under consideration. About MAGO Moon Museum MAGO Moon Museum is an online museum created by contemporary artist Shingo Nagasaka, whose works explore themes related to electronic waste issues in Agbogbloshie, Ghana. The museum provides an online space to view Nagasaka’s representative works, including pieces created from discarded electronic components found in Ghanaian slums, as well as series examining the concept of “Sustainable Capitalism.” With the implementation of the “$VIVI RWA MARKET,” viewers can deepen their understanding of the artworks while acquiring pieces aligned with the artist’s philosophy in an appropriate and structured manner. Future Developments Building on this initiative, LEGENDARY HUMANITY plans to: Expand collaborations with masterpieces across different regions and genres Strengthen international networks with artists, collectors, and researchers Advance technological development for the preservation of cultural assets for future generations and continue developing as a platform that passes humanity’s masterpieces into the future through real-world assets. Media Contact Company Name: LEGENDARY HUMANITY PTE. LTD. Address: 105 Cecil St, The Octagon 24F-2, Singapore 06953 Representative: Takamasa Suzuki, LEGENDARY HUMANITY / VIVI PROJECT Public Relations Desk Email: info@lhvivi.com Related URL: $VIVI RWA MARKET https://mondo.lhvivi.io

Commences building an RWA (Real-World Asset) token economy Maximizing Value Through Digitalization Using Cutting-Edge 3D Scanning Technology “SCAI” and RWA Indexing New York, NY – January 20, 2026 – (SeaPRwire) – VIVI PROJECT (formerly LEGENDARY HUMANITY) announces a major update and rebranding. The project utilizes the latest 3D scanning technology “SCAI” to digitally archive humanity’s cultural heritage, providing training data for AI and building a new token economy based on RWA (Real World Assets). Background and Project Evolution Previously, “LEGENDARY HUMANITY” aimed to digitize humanity’s greatest masterpieces using cutting-edge technology, teaching AI about “humanity’s magnificence” to preserve its value for future generations. With this update, the project is renamed “VIVI PROJECT.” Moving beyond mere archiving, it will challenge the creation of new value in the Web3 era as an “RWA token project” building a unique economic ecosystem backed by real-world assets (RWA). The Four Pillars of the “RWA Ecosystem” Provided by VIVI PROJECT Digitization via High-Precision 3D Scanning Technology “SCAI:DIGITAL LUMINOUS Technology” Digitizing humanity’s treasures and providing them as AI training data. Merging human wisdom with technological evolution. Adding RWA Value to VIVI COiN: Centered around the project token “VIVI COiN,” we plan to link RWA held by collectors partnered with “VIVI PROJECT” to enhance the project’s value.By using “LEGENDARY masterpieces” whose value appreciates over time as the foundation for “VIVI COiN,” we build a stable value base. Hybrid Digital & Physical Museum Collected RWAs will be displayed in both digital museums and physical exhibition facilities. Trading via the marketplace will also be enabled, enhancing liquidity as an asset. VIVI DAO’s “Buy-Back & Burn” Model The governing body, “VIVI DAO,” will use exhibition and sales revenue to implement “Buy-Back” and “Burn” of VIVI COiN. This will increase the token’s scarcity and promote long-term value appreciation. Future Outlook: Global Collection Partnerships The VIVI PROJECT is advancing the networking of collections held by global asset owners. As a first step, we have initiated the following partnerships and negotiations: LA MUSEUM: Holds one of the world’s largest legendary fashion collections, including Yves Saint Laurent, Comme des Garçons, Worlds End, Alexander McQueen, John Galliano, and Madison Martin Margiela. Major Trading Card Company: Negotiations have commenced with the world’s largest trading asset company. This will integrate Real-World Assets (RWAs) from diverse genres like fashion, art, and hobbies into the project, rapidly expanding the ecosystem. VIVI PROJECT Overview VIVI PROJECT is a next-generation platform that preserves and utilizes humanity’s greatest masterpieces in both digital and physical realms through the fusion of culture and technology. By indexing RWA, it defines new asset value in the Web3 era. Official Website: https://lhvivi.com Contact for Inquiries Contact: VIVI PROJECT PR Department Email: press@lhvivi.com

Riyadh, Saudi Arabia - 2026年1月18日 - (SeaPRwire) - 昨晚（周六），第六届欢乐奖2026在利雅得隆重举行。本次活动隶属于“利雅得季”，由沙特阿拉伯总娱乐管理局主办，并与中东广播中心建立战略合作伙伴关系。仪式在总娱乐管理局主席图尔基·阿勒谢赫阁下的出席下举行，汇聚了来自电影、电视剧、音乐、体育及数字内容领域的阿拉伯及国际顶级人物，现场媒体关注度极高，公众互动热烈。 颁奖典礼通过多个电视频道进行现场直播，并在数字平台同步播出。观众从明星们踏上薰衣草色地毯的瞬间开始，全程关注了包括奖项颁发、荣誉表彰以及多段现场音乐和表演在内的完整娱乐盛典。 当晚在充满节庆氛围的环境中拉开序幕，艺术家和名人陆续抵达，现场媒体对明星首次亮相给予了高度关注。随后，图尔基·阿勒谢赫阁下抵达现场，成为官方节目开始前的重要时刻。沙特国歌奏响后，典礼进入震撼的开场娱乐表演。 世界知名歌手凯蒂·佩里献上独具特色的开场演出，表演融合了交响乐元素、舞者与视觉特效，通过动态灯光与强烈的舞台表现力，呈现出高度制作化的艺术画面，充分体现了本届活动的规模与精密筹备。 随后，国际表演团体皮洛博鲁斯带来影子舞表演，以创新且节奏轻快的视觉形式重新吸引观众注意力。接着，颁奖环节依照流程正式展开，现场嘉宾与媒体在结果揭晓前充满期待。 拉赞·贾迈勒与梅娜·沙拉比共同颁发“最受欢迎电视剧男演员奖”。提名者包括《阿什拉街》的阿卜杜勒拉赫曼·本·纳菲亚、《码头》的阿卜杜勒莫赫森·纳默、《呼吸》的穆塔塞姆·纳哈尔，以及《非常拥挤的公寓》的希沙姆·马吉德。最终，阿卜杜勒莫赫森·纳默荣获该奖项。 随后，图芭·比尤克乌斯滕与哈利特·埃尔根奇颁发“最受欢迎黎凡特地区电视剧奖”。入围作品包括《阿塞尔》《血之中》《七层之下》和《萨尔玛》，最终《萨尔玛》获奖，剧组成员登台领奖。 在终身成就奖特别环节中，图尔基·阿勒谢赫阁下亲自表彰埃及著名画家、前文化部长法鲁克·胡斯尼，以表彰其长期以来的艺术成就与文化贡献。阁下表示能亲自授予这一荣誉深感荣幸，胡斯尼则对沙特王国、其领导层及阁下本人表达了由衷感谢。 “最受欢迎新晋电视剧明星奖”由麦·奥马尔与穆罕默德·萨米颁发。提名者包括《我的母亲》的塔拉夫·奥拜迪、《萨尔玛》的罗西尔·易卜拉欣、《无阳光》的阿里·拜亚利，以及《阿什拉街》的拉玛·阿卜杜勒瓦哈卜。最终，塔拉夫·奥拜迪获得该奖项。 随后，音乐表演再次成为焦点，安甘与波兰吉他演奏家马尔钦同台献艺，现场互动热烈。典礼继续进行，由穆罕默德·亨迪迪颁发“最受欢迎海湾地区电视剧奖”，《码头》《我的母亲》《阿什拉街》《剑99》入围，最终《阿什拉街》获奖。 “最受欢迎电视剧女演员奖”由巴里什·阿尔杜奇与汉德·埃尔切尔颁发。提名者包括《我的母亲》的阿拉努德·苏欧德、《阿什拉街》的伊勒哈姆·阿里、《无阳光》的阿米娜·哈利勒，以及《七层之下》的卡丽丝·巴沙尔。最终，卡丽丝·巴沙尔获奖。 “最受欢迎埃及电视剧奖”由李秉宪与李政宰共同颁发，入围作品包括《伊什·伊什》《非常拥挤的公寓》《艾莎的房间》《无阳光》，最终《非常拥挤的公寓》荣获该奖。 Media contact Brand: Legends PR Contact: Media Center Email: PR@legends.sa Website: https://legends.sa

Mexico City, Mexico – January 10, 2026 – (SeaPRwire) – Excent Capital has announced the launch of a new incentive program for its global partner network, offering exclusive experiences connected to the 2026 World Cu as part of its ongoing commitment to long-term collaboration and partner engagement. The initiative is designed to recognise partner performance and strengthen relationships through experiences that go beyond traditional rewards. Depending on performance tiers, partners may qualify for packages that include match tickets, travel arrangements, accommodation, and curated experiences in the United States during the tournament. Rather than focusing solely on volume, the program is structured to encourage sustainable growth, strategic alignment, and continued collaboration between Excent Capital and its partners. The incentive tiers are linked to clearly defined performance benchmarks, ensuring transparency and consistency across regions. “We work very closely with our partners on a daily basis, and this initiative is a way to give something back that goes beyond numbers,” said Andrés Espinosa, Senior Business Development Manager at Excent Capital. The World Cup 2026 incentive program is open to eligible partners worldwide and will run until May 15. Participation details, performance criteria, and tier qualifications are communicated directly to partners through Excent Capital’s regional business development teams. About Excent Capital Excent Capital is a global trading broker offering access to a wide range of financial markets. Operating on proprietary, in-house developed technology, the company focuses on transparency, execution quality, and partner-driven growth, supporting partners through education, consistent market insight, and collaborative initiatives. Contact Information Organization: Excent Capital Contact Person: Ryccielli Ongaratto, Marketing Manager Email: support@excent.capital Website: https://excent.capital/

香港 - 2026年1月5日 - (SeaPRwire) - Web3 的大规模采用，并不是通过更响亮的叙事或更锋利的口号实现的。它往往是悄然发生的——依托于逐渐隐形的基础设施，在后台无缝支撑人们的日常数字行为。而这一拐点，或许比许多人预期的更近。 iMe 是一款基于 Telegram 的超级应用，融合了即时通讯、AI 交互与去中心化金融（DeFi）。目前，iMe 在 Google Play 和 App Store 的累计下载量已突破 1700 万。其最新发布的 iMe Wallet 2.0 并不仅仅是一次版本升级，而是一次关于 Web3 交付方式的战略性转变。 iMe 并未将加密货币塑造成一种“独立体验”，而是通过 Telegram Mini App（TMA），将 Web3 功能直接嵌入 Telegram。本身。用户无需离开日常使用的聊天界面，就能与数字资产、DeFi 工具以及 AI 辅助工作流进行交互。无需额外下载应用，也无需面对陌生的用户体验，更不会出现刻意的“进入加密世界”的时刻。 在 Telegram 全球用户数逼近 9 亿的背景下，仅这一分发入口本身就代表着一次重大的规模化突破。但真正的关键，在于支撑 iMe 下一阶段增长的底层基础设施。 Attractor：为规模化社区打造的原生 Layer 2 支撑 iMe 扩张的是 Attractor —— 一个正在开发中的区块链项目，致力于构建以 zk-rollup 为核心的 Layer-2 网络，其设计目标并非服务小众的 DeFi 高阶用户，而是面向庞大且高速增长的社区型应用。 与那些主要为单一金融协议优化的通用 Layer-2 不同，Attractor 专为消息、支付、自动化和 AI 交互需要在互联网规模下即时、低成本、无感运行的场景而生。 Attractor 的核心架构特性包括： 零知识 rollup 架构，在保持 Ethereum 级安全性的同时实现高吞吐量 超低交易费用，使面向大众的微交互在经济上可行 支持 Account Abstraction 的设计，消除助记词等使用门槛，实现接近 Web2 的用户体验 原生支持 AI 驱动逻辑，使自动化与 AI agents 能够直接在链上运行 以社区为中心的网络模型，专为服务数百万用户的应用进行优化 在 Layer-2 网络上线后，从 ERC-20 向原生 Attractor 网络无缝迁移的路径 这并不是为投机而打造的基础设施，而是为已经被真实用户使用的产品而构建的。 ATTRA Token 正式上线 Attractor 已完成其原生代币 ATTRA 的 Token Generation Event（TGE）。目前，ATTRA 已作为 ERC-20 资产在去中心化交易所上线。团队已确认，在 Attractor Layer-2 主网上线后，ATTRA 将迁移至原生网络，从而在整个生态系统中释放完整的协议级效用。 这种“先流动性、后基础设施、再生态扩展”的分阶段路径，与迄今为止最成功的 Layer-2 项目高度一致。更重要的是，它将代币价值与真实产品使用深度绑定，而非依赖投机性叙事。 为什么这一时刻至关重要 这是 Web3 发展史上，首次在同一套完整技术栈中同时汇聚三大关键要素： 通过 Telegram 与 iMe 实现的大规模分发 借助 AI 驱动、用户友好交互实现的高度抽象 通过为大众参与而定制的 zk-rollup Layer-2 实现的可扩展性 在这一模式下，用户并不是“进入 Web3”，而是直接使用解决方案。区块链成为看不见的后台，而非用户感知的终点。 如果这一模式成功，iMe 与 Attractor 的协同关系将代表 Web3 增长方式的一次结构性转变：安静、原生、并以互联网规模展开。不是通过教育用户或强迫行为改变，而是通过表面熟悉、底层去中心化的产品自然发生。 这不是渐进式改良，而是那种在历史上往往预示着指数级采用的基础设施级对齐。而如果历史经验仍然适用，最具颠覆性的技术，往往不是最喧哗的——而是那些几乎不被用户察觉的存在。 媒体联系 Email: Info@attra.me Website: www.Attra.Me

香港 - 2026年1月5日 - (SeaPRwire) - Web3 的大规模采用，并不是通过更响亮的叙事或更锋利的口号实现的。它往往是悄然发生的——依托于逐渐隐形的基础设施，在后台无缝支撑人们的日常数字行为。而这一拐点，或许比许多人预期的更近。 iMe 是一款基于 Telegram 的超级应用，融合了即时通讯、AI 交互与去中心化金融（DeFi）。目前，iMe 在 Google Play 和 App Store 的累计下载量已突破 1700 万。其最新发布的 iMe Wallet 2.0 并不仅仅是一次版本升级，而是一次关于 Web3 交付方式的战略性转变。 iMe 并未将加密货币塑造成一种“独立体验”，而是通过 Telegram Mini App（TMA），将 Web3 功能直接嵌入 Telegram。本身。用户无需离开日常使用的聊天界面，就能与数字资产、DeFi 工具以及 AI 辅助工作流进行交互。无需额外下载应用，也无需面对陌生的用户体验，更不会出现刻意的“进入加密世界”的时刻。 在 Telegram 全球用户数逼近 9 亿的背景下，仅这一分发入口本身就代表着一次重大的规模化突破。但真正的关键，在于支撑 iMe 下一阶段增长的底层基础设施。 Attractor：为规模化社区打造的原生 Layer 2 支撑 iMe 扩张的是 Attractor —— 一个正在开发中的区块链项目，致力于构建以 zk-rollup 为核心的 Layer-2 网络，其设计目标并非服务小众的 DeFi 高阶用户，而是面向庞大且高速增长的社区型应用。 与那些主要为单一金融协议优化的通用 Layer-2 不同，Attractor 专为消息、支付、自动化和 AI 交互需要在互联网规模下即时、低成本、无感运行的场景而生。 Attractor 的核心架构特性包括： 零知识 rollup 架构，在保持 Ethereum 级安全性的同时实现高吞吐量 超低交易费用，使面向大众的微交互在经济上可行 支持 Account Abstraction 的设计，消除助记词等使用门槛，实现接近 Web2 的用户体验 原生支持 AI 驱动逻辑，使自动化与 AI agents 能够直接在链上运行 以社区为中心的网络模型，专为服务数百万用户的应用进行优化 在 Layer-2 网络上线后，从 ERC-20 向原生 Attractor 网络无缝迁移的路径 这并不是为投机而打造的基础设施，而是为已经被真实用户使用的产品而构建的。 ATTRA Token 正式上线 Attractor 已完成其原生代币 ATTRA 的 Token Generation Event（TGE）。目前，ATTRA 已作为 ERC-20 资产在去中心化交易所上线。团队已确认，在 Attractor Layer-2 主网上线后，ATTRA 将迁移至原生网络，从而在整个生态系统中释放完整的协议级效用。 这种“先流动性、后基础设施、再生态扩展”的分阶段路径，与迄今为止最成功的 Layer-2 项目高度一致。更重要的是，它将代币价值与真实产品使用深度绑定，而非依赖投机性叙事。 为什么这一时刻至关重要 这是 Web3 发展史上，首次在同一套完整技术栈中同时汇聚三大关键要素： 通过 Telegram 与 iMe 实现的大规模分发 借助 AI 驱动、用户友好交互实现的高度抽象 通过为大众参与而定制的 zk-rollup Layer-2 实现的可扩展性 在这一模式下，用户并不是“进入 Web3”，而是直接使用解决方案。区块链成为看不见的后台，而非用户感知的终点。 如果这一模式成功，iMe 与 Attractor 的协同关系将代表 Web3 增长方式的一次结构性转变：安静、原生、并以互联网规模展开。不是通过教育用户或强迫行为改变，而是通过表面熟悉、底层去中心化的产品自然发生。 这不是渐进式改良，而是那种在历史上往往预示着指数级采用的基础设施级对齐。而如果历史经验仍然适用，最具颠覆性的技术，往往不是最喧哗的——而是那些几乎不被用户察觉的存在。 媒体联系 Email: Info@attra.me Website: www.Attra.Me

引言 2025年第四季度，中国毛绒潮玩品类开创者「SOFTOPIA超级元气工厂」（以下简称SOFTOPIA）在国际化布局上动作频繁，接连亮相高规格文化交流活动并启动长期品牌计划，引发行业关注。作为年度最受瞩目的潮玩品牌，SOFTOPIA于今年上半年获得阅文集团独家战略投资，近期系列动作为其全球化战略落下了实质性注脚。 亮相国际慈善盛典，非遗潮玩首登世界舞台 2025年11月16日，SOFTOPIA作为现场唯一的潮玩品牌，受邀出席于新加坡滨海湾金沙酒店举办的“微博文化交流之夜”。活动聚焦“文化赋能慈善、善意联结民心”，云集了来自文化、艺术、体育及商界的国际嘉宾。 据悉，新加坡政商界高层及内阁官员受邀出席当天晚宴，并与在场的优秀华人企业代表进行了交流。 在此盛会上，SOFTOPIA荣获“微博新加坡年度ESG智造践行企业奖”。同时，品牌携手中国工艺美术大师、国家级非遗代表性传承人，正式发布全球首款非遗毛绒潮玩大娃，标志着中国非遗首次以潮玩为载体登上国际文化交流舞台。 本次活动取得了广泛的传播影响力，相关话题阅读量累计达9.3亿，视频播放量超4100万次，58次登上热搜榜。 受邀非遗推广活动，“了不起的中国潮玩”计划启动 2025年11月24日，由文化和旅游部非物质文化遗产司等单位主办的“非遗品牌推广周”及“千峰互联·搭台引商”非遗品牌资源对接活动在云南大理举行。活动汇聚了中国工商银行、抖音集团、天猫淘宝、腾讯互娱、网易、霸王茶姬等各领域代表性企业。 SOFTOPIA作为潮玩代表品牌参与其中。活动现场，其创始人正式公布“了不起的中国潮玩”长期品牌计划。该计划旨在系统性探索中国非遗与现代潮流的创新融合路径，将传统美学与工艺转化为具有全球吸引力的产品，推动传统文化的当代化表达与传播。 登陆全球顶级游戏渠道，IP商业化获国际认可 在商业拓展方面，SOFTOPIA旗下核心IP“阿豆ADOU”近期作为首个中国潮玩IP，登陆韩国现象级手游《Cookie Run: Kingdom》官方商城，其联名产品已面向全球二十多国的玩家正式发售。 《Cookie Run: Kingdom》由韩国Devsisters开发，自2021年上线以来于全球市场表现强劲。据第三方机构Sensor Tower数据显示，该游戏在2025年2月位列全球手游收入增长榜前列。 此前，其联名对象均为迪士尼、防弹少年团（BTS）等国际顶级IP与艺人。 此次成功入驻，意味着中国原创潮玩IP首次通过全球头部商业平台，直接触达海外庞大玩家社群，实现品牌从文化亮相到商业兑现的关键一跃。 结语：稳健拓展全球化版图 从开创毛绒潮玩品类市场，到获得战略投资深化IP生态，直至近期在国际文化舞台与全球商业渠道的同步推进，SOFTOPIA展现出清晰而稳健的全球化路径。通过产品创新、文化赋能与商业合作的多维布局，品牌正逐步在竞争激烈的全球潮玩市场中，构筑起坚实的差异化竞争优势。

Introduction In the fourth quarter of 2025, SOFTOPIA, the pioneer of the plush art toy category in China, accelerated its global footprint with a series of high-profile appearances at cultural exchanges and the launch of a long-term brand initiative. As one of the year's most watched brands in the sector, SOFTOPIA, which secured exclusive strategic investment from China Literature Limited earlier this year, is now putting its global strategy into substantive action. Spotlight at International Gala: Intangible Cultural Heritage Plush Collectible Debuts on World Stage On November 16, 2025, SOFTOPIA attended the “Weibo Cultural Exchange Gala” at Singapore's Marina Bay Sands as the sole art toy brand present. The gala, centered on the theme “Empowering Charity through Culture, Connecting People through Kindness,” brought together international guests from cultural, artistic, athletic, and business circles. Senior officials from Singapore's government and business community were also in attendance, engaging with leading Chinese enterprise representatives. At the event, SOFTOPIA was honored with the Weibo Singapore Award for Sustainable and Intelligent Manufacturing. In collaboration with a Chinese Master of Arts and Crafts and a national intangible cultural heritage (ICH) representative inheritor, the brand unveiled the world's first ICH-themed plush art collectible. This debut marks the first time Chinese ICH has been presented on an international cultural exchange platform through the medium of art toys. The gala achieved significant digital traction, with related topics garnering 930 million reads, video playbacks exceeding 41 million, and making 58 appearances on hot search lists. Featured at National ICH Forum: “The Great Chinese Art Toys” Unveiled On November 24, 2025, the “Intangible Cultural Heritage Brand Promotion Week” and the forum “Bridging Peaks & Businesses: A Resource Linkage Forum,” organized by the Ministry of Culture and Tourism's Intangible Cultural Heritage Department, were held in Dali, Yunnan. The event convened representatives from across industries, including the Industrial and Commercial Bank of China (ICBC), ByteDance (operator of Douyin), Alibaba Group's Tmall Taobao, Tencent Interactive Entertainment, NetEase, and CHAGEE. Participating as a representative art toy brand, SOFTOPIA’s founder unveiled the long-term brand initiative: “The Great Chinese Art Toys.” This initiative aims to systematically explore innovative avenues for integrating China's ICH with contemporary trends, transforming traditional aesthetics and craftsmanship into products with global appeal, thereby promoting the modern expression and dissemination of traditional culture. Accessing Top-Tier Global Platform: Flagship IP Gains International Commercial Recognition In a key business development, SOFTOPIA's flagship IP “ADOU” recently became the first Chinese art toy IP to launch collaborative products in the official store of the South Korean hit mobile game Cookie Run: Kingdom. The merchandise is now available to players in over twenty countries worldwide. Developed by Devsisters, Cookie Run: Kingdom has shown robust global performance since its 2021 launch. According to data from third-party analytics firm Sensor Tower, the game ranked among the top performers in worldwide mobile game revenue growth in February 2025. Its previous collaboration partners have been international top-tier IPs and artists like Disney and BTS. This successful entry represents a pivotal leap for an original Chinese art toy IP, enabling it to directly reach a vast overseas player community through a leading global commercial platform, thus transitioning from cultural visibility to tangible commercial success. Conclusion: Steadily Expanding a Global Blueprint From defining the plush art toy market to deepening its IP ecosystem with strategic investment, and now to advancing simultaneously on international cultural and commercial fronts, SOFTOPIA demonstrates a clear and steady globalization path. Through its multidimensional strategy encompassing product innovation, cultural empowerment, and strategic partnerships, the brand is progressively forging a distinctive competitive edge in the intense global art toy market.